PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23321318-1	2013	BACKGROUND & AIMS: Nucleotide polymorphisms upstream of the interleukin 28B (IL28B) gene are strongly associated with hepatitis C virus (HCV) clearance in treatment-naive patients treated with peginterferon/ribavirin (PegIFN/RBV).	peginterferon	197-210	interferon lambda 3	Homo sapiens	81-86	
23874902-1	2013	BACKGROUND/AIMS: Single-nucleotide polymorphisms (SNPs) near the interleukin 28B gene (IL28B; interferon [IFN]-lambda-3) are associated with outcomes of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection treated with peginterferon (PEG-IFN) alpha-based antiviral therapy.	peginterferon	236-249	interferon lambda 3	Homo sapiens	87-92	
32898985-0	2012	Erratum to: "Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin" [J Hepatol 2012;56:34-40].	peginterferon	128-141	interferon lambda 3	Homo sapiens	13-28	
22612303-1	2012	BACKGROUND: Polymorphisms in the IL-28B region are a strong predictor of sustained virologic response (SVR) in individual studies of HCV genotype 1 patients receiving peginterferon (pegIFN) and ribavirin.	peginterferon	167-180	interferon lambda 3	Homo sapiens	33-39	
21703176-0	2012	Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.	peginterferon	115-128	interferon lambda 3	Homo sapiens	0-15	
21739446-1	2011	An association has been reported between genetic polymorphism near IL28B gene and the prevalence of mutation of hepatitis C virus (HCV) core region residue 70, both of which have been associated with a lack of virologic response to antiviral combination therapy with peginterferon (PEG-IFN) and ribavirin.	peginterferon	267-280	interferon lambda 3	Homo sapiens	67-72	
22174846-6	2011	It was also revealed that IL28B and STAT1-nuclear translocation in hepatocytes are independent predictors of response to treatment with peginterferon and ribavirin in chronic hepatitis C patients.	peginterferon	136-149	interferon lambda 3	Homo sapiens	26-31	
22003405-1	2011	BACKGROUND: Genetic studies have demonstrated a strong association between single nucleotide polymorphisms (SNPs) at IL28B and response to treatment with peginterferon (PEG) and ribavirin (RBV) in HCV monoinfected persons.	peginterferon	154-167	interferon lambda 3	Homo sapiens	117-122